Healthcare provider profile · identity verified

Leslie Bryden, MD

Family Practice · MILWAUKIE, OR · NPI 1760634877

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	274	68
Levothyroxine Sodium	Levothyroxine Sodium	248	61
Lisinopril	Lisinopril	170	42
Gabapentin	Gabapentin	169	44
Losartan Potassium	Losartan Potassium	153	40
Sertraline Hcl	Sertraline Hcl	152	31
Hydrochlorothiazide	Hydrochlorothiazide	148	41
Oxycodone Hcl	Oxycodone Hcl	142	35
Eliquis	Apixaban	134	29
Amlodipine Besylate	Amlodipine Besylate	117	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	113	23
Escitalopram Oxalate	Escitalopram Oxalate	112	31
Omeprazole	Omeprazole	112	35
Trazodone Hcl	Trazodone Hcl	110	31
Alendronate Sodium	Alendronate Sodium	89	27
Metoprolol Succinate	Metoprolol Succinate	85	30
Simvastatin	Simvastatin	83	21
Metformin Hcl Er	Metformin Hcl	82	21
Tramadol Hcl	Tramadol Hcl	79	18
Glipizide Er	Glipizide	67	19
Olmesartan Medoxomil	Olmesartan Medoxomil	67	17
Mirtazapine	Mirtazapine	66	17
Albuterol Sulfate Hfa	Albuterol Sulfate	63	23
Spironolactone	Spironolactone	59	12
Donepezil Hcl	Donepezil Hcl	55	suppressed
Allopurinol	Allopurinol	53	11
Bupropion Xl	Bupropion Hcl	52	16
Carvedilol	Carvedilol	52	12
Venlafaxine Hcl Er	Venlafaxine Hcl	52	12
Torsemide	Torsemide	51	11
Potassium Chloride	Potassium Chloride	49	20
Fluoxetine Hcl	Fluoxetine Hcl	48	12
Meloxicam	Meloxicam	48	12
Tamsulosin Hcl	Tamsulosin Hcl	48	12
Metformin Hcl	Metformin Hcl	44	11
Montelukast Sodium	Montelukast Sodium	44	15
Rosuvastatin Calcium	Rosuvastatin Calcium	44	15
Fluticasone Propionate	Fluticasone Propionate	43	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Furosemide	Furosemide	40	13
Atenolol	Atenolol	39	12
Lorazepam	Lorazepam	39	14
Hydromorphone Hcl	Hydromorphone Hcl	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	38	12
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Memantine Hcl	Memantine Hcl	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Propranolol Hcl	Propranolol Hcl	36	11
Cephalexin	Cephalexin	35	20
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Alprazolam	Alprazolam	34	suppressed
Olanzapine	Olanzapine	34	suppressed
Ozempic	Semaglutide	33	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Prednisone	Prednisone	31	21
Ondansetron Odt	Ondansetron	30	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Famotidine	Famotidine	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Estradiol	Estradiol	23	14
Lovastatin	Lovastatin	23	suppressed
Buprenorphine	Buprenorphine	22	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Clotrimazole	Clotrimazole	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Finasteride	Finasteride	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Armour Thyroid	Thyroid,pork	18	suppressed
Erythromycin	Erythromycin Base	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Nyamyc	Nystatin	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Baclofen	Baclofen	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Clinpro 5000	Fluoride (Sodium)	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Tetrabenazine	Tetrabenazine	12	suppressed
Topiramate	Topiramate	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Nystop	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error